MBX Biosciences CFO Shift Puts Funding And Execution In Focus [Yahoo! Finance]
MBX Biosciences, Inc. (MBX)
Company Research
Source: Yahoo! Finance
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. MBX Biosciences (NasdaqGS:MBX) announced the resignation of Chief Financial Officer Richard Bartram. The company appointed John Smither as Interim CFO, effective upon Bartram's departure. Smither brings extensive prior CFO and board experience in the biopharma sector to the interim role. For a company like MBX Biosciences, which is focused on developing therapies in the biopharma space, a change at the CFO level sits at the core of how it manages cash, partnerships, and future funding options. Investors often watch this position closely because it shapes how clinical and operational priorities are supported financially. With this move, investors receive a fresh read on how NasdaqGS:MBX intends to run its finance function. Interim appointments can be a bridge to either a permanent internal choice or an external hire, and each path can influence how the company communic
Show less
Read more
Impact Snapshot
Event Time:
MBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MBX alerts
High impacting MBX Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
MBX
News
- MBX Biosciences (MBX) had its "buy" rating reaffirmed by TD Cowen.MarketBeat
- MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights [Yahoo! Finance]Yahoo! Finance
- MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate HighlightsGlobeNewswire
- MBX Biosciences Appoints Karen Basbaum as Chief Business Officer [Yahoo! Finance]Yahoo! Finance
- MBX Biosciences Appoints Karen Basbaum as Chief Business OfficerGlobeNewswire
MBX
Earnings
- 3/12/26 - Beat
MBX
Sec Filings
- 3/12/26 - Form S-3ASR
- 3/12/26 - Form S-8
- 3/12/26 - Form 10-K
- MBX's page on the SEC website